President Donald Trump announced Sunday the emergency authorization of convalescent plasma for COVID-19 patients, in a move he called "a breakthrough." Other health experts said the treatment needs more study before it's celebrated. (Aug. 23)
Subscribe for more Breaking News: smarturl.it/AssociatedPress
Website: apnews.com
Twitter: twitter.com/AP
Facebook: facebook.com/APNews
Google+: plus.google.com/115892241801867723374
Instagram: instagram.com/APNews/
You can license this story through AP Archive: aparchive.com/metadata/youtube/c382a6ad79784f3e876d87a8c2394fc9
- FDA expands access to plasma treatment for COVID-19 ( Download)
- FDA Gives Emergency Authorization For Convalescent Plasma Therapy To Be Used As Treatment For COVID- ( Download)
- What Is Blood Convalescent Plasma Therapy ( Download)
- FDA Reverses Course On Convalescent Plasma Treatment For COVID-19 ( Download)
- Trump: FDA Approval to Expand Virus Treatment With Plasma ( Download)
- Ask Dr. Nandi: FDA authorizes use of plasma from recovered patients to treat COVID-19 ( Download)
- Investigational COVID-19 Convalescent Plasma - Emergency Investigational New Drug (IND) ( Download)
- FDA approves plasma therapy treatment for coronavirus ( Download)
- Convalescent plasma therapy is a possible help against COVID-19, doctor says ( Download)
- FDA Issues Emergency Authorization For Convalescent Plasma To Treat Covid-19 ( Download)
- Coronavirus Pandemic Update 103: Convalescent Plasma Treatment & the FDA; College Campuses Close ( Download)
- U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients ( Download)
- Trump Announces Confidence In Convalescent Plasma Covid-19 Treatment ( Download)
- From Remdesivir to Human Convalescent Plasma: Understanding COVID-19 Therapeutic Development ( Download)
- FDA postpones COVID plasma approval ( Download)
